ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,473,000 | +28.8% | 935,987 | 0.0% | 0.04% | +29.6% |
| Q4 2017 | $2,696,000 | -35.9% | 935,987 | 0.0% | 0.03% | -43.8% |
| Q3 2017 | $4,203,000 | +33.9% | 935,987 | +36.9% | 0.05% | +23.1% |
| Q2 2017 | $3,138,000 | +1229.7% | 683,619 | +2241.6% | 0.04% | +875.0% |
| Q3 2016 | $236,000 | +3.5% | 29,194 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $228,000 | +1.3% | 29,194 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $225,000 | -32.4% | 29,194 | -5.3% | 0.01% | -44.4% |
| Q4 2015 | $333,000 | +56.3% | 30,844 | 0.0% | 0.01% | +50.0% |
| Q3 2015 | $213,000 | -20.5% | 30,844 | +1.8% | 0.01% | -14.3% |
| Q2 2015 | $268,000 | -50.8% | 30,300 | -45.2% | 0.01% | -50.0% |
| Q1 2015 | $545,000 | +20.3% | 55,250 | -7.6% | 0.01% | +7.7% |
| Q2 2014 | $453,000 | -45.1% | 59,800 | -40.7% | 0.01% | -94.1% |
| Q2 2013 | $825,000 | – | 100,891 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |